Marathon Petroleum vs ExxonMobil
MPC and XOM side by side, both in petroleum refining. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MPC and XOM compare
ExxonMobil is the larger company, worth 6.0 times as much as Marathon Petroleum ($680B against $113B).
On earnings, Marathon Petroleum is cheaper: it trades at 13.9× trailing earnings, against 17.1× for ExxonMobil.
ExxonMobil grew revenue faster over the last twelve months (19.0% versus 15.0% for Marathon Petroleum).
ExxonMobil keeps more of each dollar of sales as profit, with a net margin of 10.2% compared with 5.6% at Marathon Petroleum.
Both pay dividends: Marathon Petroleum yields 0.99% and ExxonMobil 2.5%.
ExxonMobil scores higher on the StockData Score (14 against 12 for Marathon Petroleum), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MPC | XOM |
|---|---|---|
| Size and price | ||
| Market cap | $113B | $680B |
| Share price | $402.84 | $166.71 |
| Change, 1 year | 105% | 41.0% |
| Change, 5 years | 568% | 175% |
| Beta (5Y) | 0.56 | 0.29 |
| Employees | 19K | 58K |
| StockData Score | ||
| Total score | 12 | 14 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 1 | 1 |
| Performance score | 3 | 3 |
| Health score | 4 | 5 (better) |
| Dividend score | 4 | 4 |
| Valuation | ||
| P/E | 13.9× (better) | 17.1× |
| P/S | 0.7× (better) | 1.7× |
| P/B | 5.9× | 2.6× (better) |
| EV/EBITDA | 8.3× | 8.2× (better) |
| P/FCF | 8.8× (better) | 15.8× |
| FCF yield | 11.4% (better) | 6.3% |
| Fair value | $336.68 | $132.85 |
| Margin of safety | −19.7% (better) | −25.5% |
| Growth | ||
| Revenue growth (TTM) | 15.0% | 19.0% (better) |
| Revenue growth, 5Y average | 13.7% (better) | 12.9% |
| Net income growth (TTM) | 301% (better) | 35.6% |
| EPS growth (TTM) | 331% (better) | 41.4% |
| Profitability | ||
| Gross margin | 12.5% | – |
| Operating margin | 9.2% | – |
| Net margin | 5.6% | 10.2% (better) |
| FCF margin | 8.4% | 10.8% (better) |
| Return on equity | 47.9% (better) | 15.4% |
| Return on invested capital | 26.0% | – |
| Financial health | ||
| Debt / equity | 1.72 | 0.13 (better) |
| Net debt / EBITDA | 1.44 | 0.26 (better) |
| Interest coverage | 8.7× | – |
| Current ratio | 1.25 (better) | 1.19 |
| Altman Z-score | 3.87 (better) | 3.65 |
| Piotroski F-score | 8 (better) | 4 |
| Dividends and buybacks | ||
| Dividend yield | 0.99% | 2.5% (better) |
| Payout ratio | 13.6% | 42.5% |
| Years of dividend growth | 4 | 16 (better) |
| Dividend growth, 5Y average | 10.0% (better) | 2.8% |
| Buyback yield | 4.4% (better) | 3.0% |
| Shareholder yield | 5.4% | 5.5% (better) |
| Ownership | ||
| Held by institutions | 78.0% | 66.5% |
| Held by insiders | 0.30% | 0.00% |
| Insider net buying, 12 months | −$13.9M | – |
| Superinvestors holding | 1 | 3 (better) |
| Short interest, % of float | 2.3% | 1.1% |
Go deeper
- MPC stock overview
- MPC income statement
- MPC valuation and score
- XOM stock overview
- XOM income statement
- XOM valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.